Cargando…
BLT2, a leukotriene B(4) receptor 2, as a novel prognostic biomarker of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is considered to be a notorious type of cancer due to its aggressive metastatic potential and poor prognosis. Recent evidence suggests that BLT2, a low-affinity LTB(4) receptor is critically associated with the phenotypes of TNBC cells, including invasion, metast...
Autores principales: | Park, JaeIn, Jang, Jae-Hyun, Park, Geun-Soo, Chung, Yunro, You, Hye Jin, Kim, Jae-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130834/ https://www.ncbi.nlm.nih.gov/pubmed/29898809 http://dx.doi.org/10.5483/BMBRep.2018.51.8.127 |
Ejemplares similares
-
Leukotriene B4 receptor-2 contributes to KRAS-driven lung tumor formation by promoting interleukin-6-mediated inflammation
por: Jang, Jae-Hyun, et al.
Publicado: (2021) -
Contributory Role of BLT2 in the Production of Proinflammatory Cytokines in Cecal Ligation and Puncture-Induced Sepsis
por: Park, Donghwan, et al.
Publicado: (2021) -
Anti-inflammatory action of ethanolic extract of Ramulus mori on the BLT2-linked cascade
por: Park, Geun-Soo, et al.
Publicado: (2016) -
Differential Contribution of BLT(1) and BLT(2) to Leukotriene B(4)-Induced Human NK Cell Cytotoxicity and Migration
por: Wang, Meng, et al.
Publicado: (2015) -
BLT2 Up-Regulates Interleukin-8 Production and Promotes the Invasiveness of Breast Cancer Cells
por: Kim, Hyunju, et al.
Publicado: (2012)